Suplicy H - Search Results

Year	Number of Results
1952	1
2002	1
2003	2
2005	1
2006	1
2008	1
2009	2
2010	2
2013	1
2014	1
2015	1
2020	1
2021	1
2024	0

1

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.

2

Infeccions as the etiology for obesity.

Suplicy Hde L, Bornschein A. Suplicy Hde L, et al. Arq Bras Endocrinol Metabol. 2009 Mar;53(2):159-64. doi: 10.1590/s0004-27302009000200007. Arq Bras Endocrinol Metabol. 2009. PMID: 19466208 Review.

3

[Brazilian Consensus on second-generation antipsychotics and metabolic disorders].

Elkis H, Gama C, Suplicy H, Tambascia M, Bressan R, Lyra R, Cavalcante S, Minicucci W. Elkis H, et al. Among authors: suplicy h. Braz J Psychiatry. 2008 Mar;30(1):77-85. doi: 10.1590/s1516-44462008000100014. Braz J Psychiatry. 2008. PMID: 18373022 Free article. Portuguese.

4

[Polycystic kidney].

LIMA EC, DE SUPLICY HL, ROCHA JA. LIMA EC, et al. Among authors: de suplicy hl. Arch Med Panamenos. 1952 Jul-Dec;21(2):87-100. Arch Med Panamenos. 1952. PMID: 13047969 Undetermined Language. No abstract available.

5

Personality type, eating behaviour and suicide risk in women in treatment for obesity.

de Figueiredo MDD, Nasser SN, Franco CB, Dos Santos CB, Boguszewski CL, Suplicy HL, Rodrigues AM, Radominski RB. de Figueiredo MDD, et al. Among authors: suplicy hl. Eat Weight Disord. 2021 Mar;26(2):547-554. doi: 10.1007/s40519-020-00877-9. Epub 2020 Mar 14. Eat Weight Disord. 2021. PMID: 32172507

6

Butyrylcholinesterase activity and metabolic syndrome in obese patients.

Alcântara VM, Oliveira LC, Réa RR, Suplicy HL, Chautard-Freire-Maia EA. Alcântara VM, et al. Among authors: suplicy hl. Clin Chem Lab Med. 2005;43(3):285-8. doi: 10.1515/CCLM.2005.048. Clin Chem Lab Med. 2005. PMID: 15843232

7

The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.

Rodrigues AM, Radominski RB, Suplicy Hde L, De Almeida SM, Niclewicz PA, Boguszewski CL. Rodrigues AM, et al. Among authors: suplicy hde l. J Clin Endocrinol Metab. 2002 Apr;87(4):1621-6. doi: 10.1210/jcem.87.4.8420. J Clin Endocrinol Metab. 2002. PMID: 11932292 Clinical Trial.

8

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators. James WP, et al. N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114. N Engl J Med. 2010. PMID: 20818901 Free article. Clinical Trial.

9

A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.

Suplicy H, Boguszewski CL, dos Santos CM, do Desterro de Figueiredo M, Cunha DR, Radominski R. Suplicy H, et al. Int J Obes (Lond). 2014 Aug;38(8):1097-103. doi: 10.1038/ijo.2013.225. Epub 2013 Nov 29. Int J Obes (Lond). 2014. PMID: 24287940 Clinical Trial.

10

Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5- phenotypes.

Alcântara VM, Oliveira LC, Réa RR, Suplicy HL, Chautard-Freire-Maia EA. Alcântara VM, et al. Among authors: suplicy hl. Int J Obes Relat Metab Disord. 2003 Dec;27(12):1557-64. doi: 10.1038/sj.ijo.0802464. Int J Obes Relat Metab Disord. 2003. PMID: 14634689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year